Previous close | 1.2500 |
Open | 1.2500 |
Bid | 0.0000 |
Ask | 1.2500 |
Strike | 4.00 |
Expiry date | 2024-08-16 |
Day's range | 1.2500 - 1.2500 |
Contract range | N/A |
Volume | |
Open interest | 2 |
Key Insights The projected fair value for CureVac is US$5.84 based on 2 Stage Free Cash Flow to Equity CureVac is...
GSK revamps its existing collaboration deal with partner CureVac, converting it from a collaboration deal into a licensing agreement related to mRNA vaccine candidates for COVID-19 and influenza.
GSK and CureVac (CVAC) are in the spotlight following a restructuring of their vaccine agreement.